AKT1 and neoplasm: Its ability to suppress T-cell activation leads to the successful immune evasion of the tumor while its contribution to the prompting of pathways such as the PI3K/Akt and STAT3 pathways can enhance survival and proliferation, further increasing the tumor’s resistance (26, 27).